Paediatric Haematology Oncology Division, Department of Paediatrics, VU University Medical Centre, Vrije University, Amsterdam, The Netherlands.
Arch Dis Child. 2010 Jan;95(1):20-5. doi: 10.1136/adc.2008.154138. Epub 2009 Aug 12.
Previously, treatment and the results of treatment for childhood acute lymphoblastic leukaemia (ALL) in Indonesia differed significantly between poor and prosperous patients. Poor patients received less individual attention from oncologists and access to parental education and donated chemotherapy was lacking.
A structured parental education programme for both poor and prosperous parents was introduced in January 2004 to improve access to parental education and donated chemotherapy. The programme consisted of a video presentation, an information booklet, DVD, audiocassette, a statement-of-understanding for donated chemotherapy, and a complaints procedure. Informed consent was also sought.
Our study compared childhood ALL treatment outcome before and after the introduction of the parental education programme.
The medical records of 283 children with ALL diagnosed before (1997-2002; n = 164) and after (2004-2006; n = 119) the introduction of the education programme were reviewed. Data on treatment results and parental socioeconomic status were collected.
After the introduction of the education programme, treatment refusal decreased (from 14% to 2%) and event-free survival increased (from 13% to 29%) significantly among poor patients. Treatment dropout increased (from 0% to 13%) significantly among prosperous patients. Overall, toxic death (from 23% to 36%) increased significantly, but there was no significant difference in event-free survival.
After introduction of the programme, treatment refusal decreased and event-free survival increased significantly among poor families. However, improved knowledge, skills and communication are still required to combat the high rates of toxic death and treatment dropout. Treatment intensity should be accompanied by improved supportive care.
此前,印度尼西亚儿童急性淋巴细胞白血病(ALL)的治疗和治疗结果在贫困和富裕患者之间存在显著差异。贫困患者接受的肿瘤医生个体关注较少,获得的父母教育和捐赠化疗也不足。
2004 年 1 月,引入了一项针对贫困和富裕父母的结构化父母教育计划,以改善父母教育和捐赠化疗的可及性。该计划包括视频演示、信息手册、DVD、录音带、捐赠化疗的理解声明以及投诉程序。还征求了知情同意。
我们的研究比较了引入父母教育计划前后儿童 ALL 治疗结果。
回顾了 283 名 ALL 患儿的病历,这些患儿在教育计划引入前(1997-2002 年;n = 164)和引入后(2004-2006 年;n = 119)进行了诊断。收集了治疗结果和父母社会经济地位的数据。
教育计划引入后,贫困患者的治疗拒绝率(从 14%降至 2%)和无事件生存率(从 13%升至 29%)显著增加。富裕患者的治疗辍学率(从 0%升至 13%)显著增加。总体而言,毒性死亡率(从 23%升至 36%)显著增加,但无事件生存率无显著差异。
计划引入后,贫困家庭的治疗拒绝率下降,无事件生存率显著提高。然而,仍然需要提高知识、技能和沟通能力,以应对高毒性死亡率和治疗辍学率。治疗强度应辅以改善的支持性护理。